A team from The Institute of Cancer Research, London, has developed a new immuno-PET imaging technique that could spot which ...

A new imaging technique could mean patients with aggressive brain tumours benefit from cutting edge immunotherapy treatments, ...

Amyloid alone does not confirm that Alzheimer's disease is progressing rapidly. Here's what people need to know about the ...

The FDA accepted the new drug application for TLX101-CDx and granted priority review to the agent in glioma. The FDA has ...

Telix Pharmaceuticals leverages a novel theranostic approach, offering a unique risk-reward model in the challenging biotech ...

Primary factor driving demand for PET MRI systems is their increasing utilization in various healthcare fields such as neurology, cardiology, oncology, and musculoskeletal imaging. These systems ...

A new PET scan reliably detects benign tumors in the pancreas, according to research led by Radboud university medical center.

Roche put forward new data on two of its upcoming, non-invasive blood tests designed to help rule out a diagnosis of ...

The science around dementia and Alzheimer's disease has grown over the past two decades. Thousands of area residents have played a notable role in those advances.

MELBOURNE, Australia, Oct. 24, 2024 (GLOBE NEWSWIRE) -- (ASX: TLX, Telix, the Company) today announces that the United States (U.S.) Food and Drug Administration (FDA) has accepted ...

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the United States (U.S.) Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for TLX101-CDx ...

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the United States (U.S.) Food and Drug Administration (FDA) has ...